On Tuesday 03 December, the Essex Neurology Network in partnership with Healthwatch Essex have launched an e-learning tool for health and social care professionals. The tool, ‘Understanding Neurology...
A new study has found further evidence that changes to the gut microbiome play a role in the development of multiple sclerosis (MS). Scientists at the New York School of Medicine found that newly...
Scientists have moved a step closer to blocking the progression of multiple sclerosis (MS) by lessening the flow of B-cells into the brain, according to a new study.
In a healthy brain, the blood-...
New research has found that an investigational targeted therapy called CD45-ADC can reset the normal function of the immune system in a mouse model of multiple sclerosis (MS). CD45-ADC is an antibody...
The Personal Independence Payment (PIP) application process is ‘humiliating and degrading’ and is ‘cheating people with multiple sclerosis (MS) out of vital support’, according to new research by the...
A new study from the University Of Virginia School Of Medicine has discovered that oligodendrocyte progenitor cells are key contributors to the development of multiple sclerosis (MS).
These cells are...
Today is Purple Tuesday, an international call to action to customer-facing businesses to put accessibility at the forefront of their company.
Coordinated by Purple, a disability organisation, the...
Medical cannabis has been approved for use on the NHS in England for people with multiple sclerosis (MS) for the first time.
The National Institute for Health and Care Excellence (NICE) has given the...
Important work by scientists to discover how oxygen affects the body at a cellular level has been recognised with a Nobel Prize. William Kaelin of the Dana-Farber Cancer Institute and Harvard Medical...
As many as 20,000 people in the UK are going to be given medical cannabis as part of a new study aiming to create the largest body of evidence on the drug’s clinical effects.
The trial, named...
